Background There is growing concern about possible cognitive consequences of COVID-19,
with reports of ‘Long COVID' symptoms persisting into the chronic phase and case studies …

Background Neuroimaging studies have shown structural alterations in several brain regions
in children and adults with attention deficit hyperactivity disorder (ADHD). Through the …

Δ-9-tetrahydrocannabinol (Δ-9-THC) and Cannabidiol (CBD), the two main ingredients of the
Cannabis sativa plant have distinct symptomatic and behavioral effects. We used functional …

The indirect catecholamine agonist methylphenidate (Ritalin) is the drug treatment of choice
in attention deficit/hyperactivity disorder (AD/HD), one of the most common behavioral …

The adoption into the UK of children who have been reared in severely deprived conditions
provides an opportunity to study possible association between very early negative …

Efficient behavior involves the coordinated activity of large-scale brain networks, but the
way in which these networks interact is uncertain. One theory is that the salience network (SN)—…

Objective: Neuroimaging studies show structural alterations of various brain regions in children
and adults with attention deficit hyperactivity disorder (ADHD), although nonreplications …

Objective: Catecholamine stimulant drugs are highly efficacious treatments for attention
deficit/hyperactivity disorders (AD/HD). Catecholamine modulation in humans influences …

Attempts to improve cognitive function in patients with brain disorders have become the
focus of intensive research efforts. A recent emerging trend is the use of so-called cognitive …

Preclinical studies suggest that ketamine-induced psychopathology is mediated, in part, by
increased glutamate release, hypothesized to occur via inhibition of GABAergic interneurons. …